Glucagon-like peptide-1 (GLP-1) analogs have emerged as a compelling therapeutic target for managing metabolic syndromes. These naturally occurring substances are secreted by the gut in response to nutrient intake, https://thebookmarkplaza.com/story20381230/unveiling-the-therapeutic-potential-of-glp-1-peptides